Background illustration for clinical trials search

Paid Clinical Trials Alberta

Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

for
Renal Cell Carcinoma
Location: Boston MA, New York NY, Philadelphia PA, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07195682

Phase1, Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Stony Brook NY, Lake Success NY, Rego Park NY,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06686771

Phase3, Recruiting

Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates

for
Neonatal Resuscitation, Apnea Neonatal
Location: Montral, Montreal, Toronto, Hamilton, Edmonton, Calgary,
Sponsor: Michelle Baczynski

Sex: All

Age: 0

Code: NCT06849596

Recruiting

Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

for
Pediatric Low-grade Glioma
Location: Quebec, Sherbrooke, Montreal, Toronto, London, Winnipeg,
Sponsor: St. Justine's Hospital

Sex: All

Age: 2 - 25

Code: NCT06666348

Phase1, Phase2, Recruiting

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Montreal, Ottawa, Kingston, Toronto, Mississauga,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06880523

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients

for
Burn Scar, Burn Wound
Location: Hamilton, Edmonton
Sponsor: Birch BioMed Inc

Sex: All

Age: 12 - 65

Code: NCT06807021

Phase2, Phase3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Worcester MA, Hartford CT, Norwalk CT, Danbury CT,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

for
Chronic Spontaneous Urticaria
Location: Quebec, White Marsh MD, Ottawa, Niagara Falls,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07219615

Phase2, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase3, Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Fairfax VA, Rochester MN, Dallas TX, Calgary,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07054515

Phase3, Recruiting

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Quebec, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07088926

Phase2, Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

for
Systemic Lupus Erythematosus (SLE)
Location: Calgary, West Long Branch NJ, Brooklyn NY, Ottawa,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 16+

Code: NCT07175285

Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Bangor ME, Boston MA, Providence RI, Manchester NH,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Taurine Supplementation in Long COVID

for
Long COVID
Location: Montreal, Toronto, Edmonton, Vancouver
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06721949

Phase2, Phase3, Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Boston MA, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase2, Phase3, Recruiting

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for
Atrial Fibrillation
Location: Halifax, Sherbrooke, New York NY, Montreal, Camden NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07217067

Phase2, Recruiting

Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).

for
Crohn's Disease of Both Small and Large Intestine
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 0 - 70+

Code: NCT07246460

Recruiting

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07175428

Phase2, Recruiting

PROMIS and Mobility Evaluation in Sarcoma Patients

for
Sarcoma, Giant Cell Tumor of Bone
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07227961

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase3, Recruiting